Profile

Mr. Kyle M.
Lauzon
is a Director-Institutional Sales Group at C.
K.
Cooper & Co. He joined C.
K.
Cooper & Co. in October 2009.
He has 18 years experience in the financial services sector and for the last 10 years has been exclusively focused on institutional research sales in the healthcare and technology sectors.
Most recently, he was a Managing Director of Institutional Equity Sales at Biologic Investment Research, LLC.
Prior to joining Biologic Investment Research, LLC, Mr. Lauzon was the Director of Institutional Equity Sales for Dawson James Securities.
At Dawson James, he was responsible for building out the institutional equities distribution and trading platforms.
Mr. Lauzon also developed and managed regular expert led conference calls, surveys as well as both deal and non-deal corporate road shows.
Mr. Lauzon received multiple awards while at Dawson James in 2006 & 2007 for top institutional production.
In late 2001, Mr. Lauzon joined Sterling Financial Investment Group as an institutional sales representative where by the end of 2002 he had become the desk's top producer and was awarded "MVP" status for his exceptional performance.He holds series 7, 24, and 63 securities licenses.

Former positions of Kyle M. Lauzon

CompaniesPositionEnd
Institutional Sales 31/10/2010
Trading-Equity 29/09/2009
Institutional Sales 30/12/2008
Institutional Sales -
See the detail of Kyle M. Lauzon's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kyle M. Lauzon's experience

Connections

11

1st degree connections

4

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies4

Finance

Finance

Finance

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Kyle M. Lauzon